This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alfaidy, N. Articles by Challis, J. Search for Related Content PubMed PubMed Citation Articles by Alfaidy, N. Articles by Challis, J.

Late Gestation Increase in 11ß-Hydroxysteroid Dehydrogenase 1 Expression in Human Fetal Membranes: A Novel Intrauterine Source of Cortisol

Canadian Institutes for Health Research (CIHR), Institute of Human Development, Child and Youth Health, Department of Obstetrics and Gynecology, and Department of Physiology (N.A., W.L., T.M., J.C.), University of Toronto, Toronto, Ontario, Canada M5S 1A8; and CIHR Group in Fetal and Neonatal Health and Development, Department of Obstetrics and Gynecology (K.Y., J.C.), University of Western Ontario, London, Ontario, Canada N6A 5B8

Address all correspondence and requests for reprints to: Dr. Nadia Alfaidy, University of Toronto, Department of Physiology, Medical Sciences Building (MSB) Room 3344, 1 King’s College Circle, Toronto, M5S 1A8, Ontario, Canada. E-mail: n.alfaidy{at}utoronto.ca.

Late human gestation is associated with an increase in the concentration of cortisol (F) in the fetal circulation and amniotic fluid. It had been assumed that most of the F measured in the amniotic fluid came from the fetal adrenal gland. However, local production of F can also occur in human intrauterine tissues from inactive cortisone under the influence of the enzyme 11ß-hydroxysteroid dehydrogenase (11ß-HSD) type 1. Recent studies have shown that 11ß-HSD 1 activity is up-regulated by prostaglandins (PG) E2 and F2, hormones that are produced in the fetal membranes (FM) at term. In the present study, we hypothesized that 11ß-HSD 1 expression would increase in FM during pregnancy and at labor, creating the potential for local increase in F production at term. We examined 11ß-HSD 1 expression in placenta and FM obtained during normal pregnancy from nonlaboring women [26–28 wk (n = 3); 29–30 wk (n = 3); 32–33 wk (n = 3); 35–36 wk (n = 3)] and from uncomplicated term pregnancies after elective cesarean section (n = 6). 11ß-HSD 1 expression was also examined in amnion and chorionic tissues in relation to term labor (n = 12). Immunohistochemistry and Western blot analysis were used to examine 11ß-HSD 1 localization and expression. 11ß-HSD 1 activity was also measured in microsomal fractions prepared from whole fetal membranes. At term, immunoreactive 11ß-HSD 1 expression was localized predominantly to the chorion trophoblast cells, attached decidua, and amnion epithelial cells. 11ß-HSD 1 expression in FM increased with gestational age and reflected increased enzyme reductase activity. No change in 11ß-HSD 1 expression was found in placental tissue from the same patients. There was a significant increase in 11ß-HSD 1 expression in amnion but not in chorion with the onset of labor. We suggest that increases in 11ß-HSD 1 expression/activity by intrauterine membranes during late gestation may result in increased potential for a local increase in F production and that FM should be considered as an extraadrenal source of F during late gestation. This local F production may be involved in different pathways contributing to the regulation of parturition.

This work was supported by the Canadian Institutes for Health Research in Human Development, Child, and Youth Health (MOP 42378 to J.C.).

Abbreviations: E, Inactive cortisone; F, cortisol; 11ß-HSD, 11ß-hydroxysteroid dehydrogenase; IHC, immunohistochemical analysis; NADPH, nicotinamide adenosine dinucleotide phosphate; PG, prostaglandin; PGDH, PG dehydrogenase.

This article has been cited by other articles:

				K. L. Connor, J. R. G. Challis, P. van Zijl, C. W. Rumball, S. Alix, A. L. Jaquiery, M. H. Oliver, J. E. Harding, and F. H. Bloomfield Do Alterations in Placental 11{beta}-Hydroxysteroid Dehydrogenase (11{beta}HSD) Activities Explain Differences in Fetal Hypothalamic-Pituitary-Adrenal (HPA) Function Following Periconceptional Undernutrition or Twinning in Sheep? Reproductive Sciences, December 1, 2009; 16(12): 1201 - 1212. [Abstract] [PDF]

				H.-Y. Lee, T. J. Acosta, D. J. Skarzynski, and K. Okuda Prostaglandin F2alpha Stimulates 11Beta-Hydroxysteroid Dehydrogenase 1 Enzyme Bioactivity and Protein Expression in Bovine Endometrial Stromal Cells Biol Reprod, April 1, 2009; 80(4): 657 - 664. [Abstract] [Full Text] [PDF]

				Z. Yang, P. Zhu, C. Guo, X. Zhu, and K. Sun Expression of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 in Human Fetal Lung and Regulation of Its Expression by Interleukin-1{beta} and Cortisol J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 306 - 313. [Abstract] [Full Text] [PDF]

				K. Vagnerova, Z. Vackova, P. Klusonova, F. Staud, M. Kopecky, P. Ergang, I. Miksik, and J. Pacha Reciprocal Changes in Maternal and Fetal Metabolism of Corticosterone in Rat During Gestation Reproductive Sciences, November 1, 2008; 15(9): 921 - 931. [Abstract] [PDF]

				A. E. Michael and A. T. Papageorghiou Potential significance of physiological and pharmacological glucocorticoids in early pregnancy Hum. Reprod. Update, September 1, 2008; 14(5): 497 - 517. [Abstract] [Full Text] [PDF]

				Z. Yang, C. Guo, P. Zhu, W. Li, L. Myatt, and K. Sun Role of glucocorticoid receptor and CCAAT/enhancer-binding protein {alpha} in the feed-forward induction of 11{beta}-hydroxysteroid dehydrogenase type 1 expression by cortisol in human amnion fibroblasts J. Endocrinol., November 1, 2007; 195(2): 241 - 253. [Abstract] [Full Text] [PDF]

				J. Chan, E. H Rabbitt, B. A Innes, J. N Bulmer, P. M Stewart, M. D Kilby, and M. Hewison Glucocorticoid-induced apoptosis in human decidua: a novel role for 11{beta}-hydroxysteroid dehydrogenase in late gestation J. Endocrinol., October 1, 2007; 195(1): 7 - 15. [Abstract] [Full Text] [PDF]

				M. Takano, Z. Lu, T. Goto, L. Fusi, J. Higham, J. Francis, A. Withey, J. Hardt, B. Cloke, A. V. Stavropoulou, et al. Transcriptional Cross Talk between the Forkhead Transcription Factor Forkhead Box O1A and the Progesterone Receptor Coordinates Cell Cycle Regulation and Differentiation in Human Endometrial Stromal Cells Mol. Endocrinol., October 1, 2007; 21(10): 2334 - 2349. [Abstract] [Full Text] [PDF]

				K. Sun, D. Brockman, B. Campos, B. Pitzer, and L. Myatt Induction of Surfactant Protein A Expression by Cortisol Facilitates Prostaglandin Synthesis in Human Chorionic Trophoblasts J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4988 - 4994. [Abstract] [Full Text] [PDF]

				K. C. Jonas, C. Chandras, D. R. E. Abayasekara, and A. E. Michael Role for Prostaglandins in the Regulation of Type 1 11{beta}-Hydroxysteroid Dehydrogenase in Human Granulosa-Lutein Cells Endocrinology, December 1, 2006; 147(12): 5865 - 5872. [Abstract] [Full Text] [PDF]

				A. Ball, J. W. Wang, S. Wong, B. Zielnik, J. Mitchell, N. Wang, M. B. Stemerman, and B. F. Mitchell Phorbol ester treatment of human myometrial cells suppresses expression of oxytocin receptor through a mechanism that does not involve activator protein-1 Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E922 - E928. [Abstract] [Full Text] [PDF]

				A Luczay, D Torok, A Ferenczi, J Majnik, J Solyom, and G. Fekete Potential advantage of N363S glucocorticoid receptor polymorphism in 21-hydroxylase deficiency. Eur. J. Endocrinol., June 1, 2006; 154(6): 859 - 864. [Abstract] [Full Text] [PDF]

				W. Li, L. Gao, Y. Wang, T. Duan, L. Myatt, and K. Sun Enhancement of Cortisol-Induced 11{beta}-Hydroxysteroid dehydrogenase Type 1 Expression by Interleukin 1{beta} in Cultured Human Chorionic Trophoblast Cells Endocrinology, May 1, 2006; 147(5): 2490 - 2495. [Abstract] [Full Text] [PDF]

				V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus Endocr. Rev., April 1, 2006; 27(2): 141 - 169. [Abstract] [Full Text] [PDF]

				P. Hoffmann, J.-J. Feige, and N. Alfaidy Expression and Oxygen Regulation of Endocrine Gland-Derived Vascular Endothelial Growth Factor/Prokineticin-1 and Its Receptors in Human Placenta during Early Pregnancy Endocrinology, April 1, 2006; 147(4): 1675 - 1684. [Abstract] [Full Text] [PDF]

				M. D. Mitchell, M. C. Chang, T. Chaiworapongsa, H.-Y. Lan, R. J. A. Helliwell, R. Romero, and T. A. Sato Identification of 9{alpha},11{beta}-Prostaglandin F2 in Human Amniotic Fluid and Characterization of Its Production by Human Gestational Tissues J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4244 - 4248. [Abstract] [Full Text] [PDF]

				J. F. Johnstone, A. D. Bocking, E. Unlugedik, and J. R.G. Challis The Effects of Chorioamnionitis and Betamethasone on 11{beta}, Hydroxysteroid Dehydrogenase Types 1 and 2 and the Glucocorticoid Receptor in Preterm Human Placenta Reproductive Sciences, May 1, 2005; 12(4): 238 - 245. [Abstract] [PDF]